1. White House. Readout of the vice president’s meeting with right to try advocates.
https://www.whitehouse.gov/the-press-office/2017/02/07/readout-vice-presidents-meeting-right-try-advocates
. Accessed 15 Feb 2017.
2. U.S. Food and Drug Administration. Expanded access INDs and protocols 2009–2015.
http://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/ucm443572.htm
. Accessed 15 Feb 2017.
3. U.S. Food and Drug Administration. Expanded access (compassionate use)
https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/default.htm
. Accessed 23 June 2017.
4. U.S. Food and Drug Administration. Charging for investigational drugs under an IND—questions and answers, guidance for industry.
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM351264.pdf
Accessed 23 June 2017.
5. Jarow JP, Lurie P, Ikenberry SC, Lemery S. Overview of FDA’s expanded access program for investigational drugs. Ther Innov Regul Sci. 2017;51(2):177–9. doi:
10.1177/2168479017694850
.